Location History:
- San Diego, CA (US) (2011)
- Silver Spring, MD (US) (2015)
- Kensington, MD (US) (2013 - 2018)
Company Filing History:
2 out of 130 
2 out of 576 
2 out of 1,187 
Years Active: 2011-2018
Title: Godfrey Jonah Anderson Rainey: Innovator in Biopharmaceuticals
Introduction
Godfrey Jonah Anderson Rainey is a notable inventor based in Kensington, MD (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of 4 patents. His work primarily focuses on developing innovative therapeutic solutions for various diseases and disorders.
Latest Patents
Rainey's latest patents include groundbreaking inventions such as covalently-associated diabody complexes that possess charged coil domains. These complexes are capable of enhanced binding to serum albumin and are designed for the treatment of a variety of diseases, including immunological disorders, infectious diseases, intoxication, and cancers. The diabody molecules consist of two polypeptide chains that form at least two epitope binding sites, which can recognize the same or different epitopes on various antigens. Additionally, his patents cover Fc region-containing polypeptides that exhibit improved effector function due to alterations in fucosylation. These innovations are particularly useful in treating or preventing cancer and other diseases by enhancing the efficacy of effector cell functions.
Career Highlights
Throughout his career, Rainey has worked with prominent organizations such as Macrogenics, Inc. and The Salk Institute for Biological Studies. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biopharmaceutical research.
Collaborations
Some of Rainey's notable coworkers include Leslie Sydnor Johnson and John Young. Their collaborative efforts have further enriched the research and development of innovative therapeutic solutions.
Conclusion
Godfrey Jonah Anderson Rainey is a distinguished inventor whose work in biopharmaceuticals has the potential to transform treatment options for various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.